Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
1,902.00    16.00 (0.85%)
Bid:
1,910.00
Ask:
1,911.00
Spread: 1.00 (0.052%)
Market Cap: £3.19b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Directorate Change

16 Apr 2018 07:25

RNS Number : 9451K
Johnson Matthey PLC
16 April 2018
 

Johnson Matthey Plc announces Patrick Thomas as Chairman Designate

 

The Board of Directors of Johnson Matthey Plc is pleased to announce that Patrick Thomas will succeed Tim Stevenson as Chairman.

 

Patrick will join the board as Non-Executive Director and Chairman Designate on 1st June 2018. He will be appointed as Chairman of the board with effect from the end of the Annual General Meeting on 26th July 2018 when Tim Stevenson retires, after seven years as Chairman.

 

Patrick has deep experience in leading international speciality chemicals businesses. He brings to Johnson Matthey an impressive track record of driving growth through science and innovation across global markets. Since 2015 Patrick has been Chief Executive Officer and Chairman of the Board of Management of Covestro AG, a world leading polymers business. Between 2007 and 2015 he was also Chief Executive Officer of its predecessor, Bayer MaterialScience, prior to its demerger from Bayer AG. Patrick will step down from his role at Covestro AG at the end of May 2018.

 

Before joining Bayer, Patrick spent five years with the global chemical company, Huntsman Corporation, including as President of its Polyurethanes, Performance and Advanced Materials divisions. Prior to this he was Chief Executive of ICI’s polyurethanes business and led its integration into Huntsman. In his earlier career, Patrick held a number of global and regional roles in ICI.

 

Patrick also has strong board experience. He is currently an independent non-executive director of Akzo Nobel N.V., the paints, coating and specialty chemicals group. He was previously an independent non-executive director and member of the Audit and Remuneration Committees of BG Group plc from December 2010 to February 2016.

 

Patrick’s background is in Engineering Science; he has an MA from Oxford University, is a Fellow of the Royal Academy of Engineering and a Fellow of the Institute of Engineering and Technology.

 

Commenting on Patrick’s appointment, Tim Stevenson, Chairman of Johnson Matthey, said:

 

"I am thrilled that the board has chosen Patrick to succeed me as Chairman. Patrick brings a valuable combination of extensive board experience and recent executive leadership of major global organisations. I am confident that he will successfully steer Johnson Matthey to deliver continued value for our shareholders as we pursue our vision to make the world a cleaner and healthier place."

 

Robert MacLeod, Chief Executive of Johnson Matthey, added:

 

"I am delighted to welcome Patrick as the future Chairman of Johnson Matthey and look forward to working with him as we deliver our growth strategy."

 

Commenting on his appointment, Patrick Thomas said:

 

“I am really excited to be joining Johnson Matthey, a company with a strong reputation for science and a great team of people. I am looking forward to joining the board as we continue to evolve and grow, creating value for our shareholders and for the world around us.”

 

 

Disclosures required pursuant to Rule 9.6.13 of the Listing Rules of the Financial Conduct Authority (including directorships held in other publicly quoted companies at any time in the previous five years):

 

Patrick was appointed as a non-executive director and member of the supervisory board of Akzo Nobel N.V. in November 2017, a company listed on the stock exchange of Euronext Amsterdam.

 

Since August 2015, Patrick has been Chief Executive Officer and Chairman of the Board of Management of Covestro AG, a company listed on the Frankfurt Stock Exchange.

 

From December 2010 to February 2016, Patrick was a non-executive director of BG Group Plc, a company listed on the London Stock Exchange.

 

Other than as stated in this announcement, there are no other disclosures required pursuant to Rule 9.6.13 of the Listing Rules of the Financial Conduct Authority.

 

Enquiries:

 

 

 

Analysts and investors:

 

Martin Dunwoodie

+44 (0)20 7269 8241

Simon McGough

+44 (0)20 7269 8235

Katharine Burrow

+44 (0)20 7269 8444

 

 

Media:

 

Sally Jones

+44 (0)20 7269 8407

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFMGMDLKRGRZG
Date   Source Headline
3rd Jul 20243:24 pmRNSHolding(s) in Company
3rd Jul 20247:00 amRNSShare buyback programme
2nd Jul 20243:04 pmRNSHolding(s) in Company
1st Jul 20242:38 pmRNSCompletion of Medical Device Components sale
1st Jul 20247:00 amRNSDirectorate Change
27th Jun 20245:54 pmRNSHolding(s) in Company
27th Jun 202412:03 pmRNSHolding(s) in Company
27th Jun 20247:00 amRNSJohnson Matthey: PGM Services seminar
25th Jun 202410:35 amRNSHolding(s) in Company
20th Jun 202412:24 pmRNSDirector/PDMR Shareholding
14th Jun 20243:00 pmRNSHolding(s) in Company
6th Jun 20249:00 amRNSAnnual Financial Report
28th May 202410:13 amRNSHolding(s) in Company
23rd May 20247:00 amRNSJohnson Matthey Full Year Results
21st May 20245:04 pmRNSHolding(s) in Company
20th May 20245:04 pmRNSHolding(s) in Company
16th May 20244:43 pmRNSDirector/PDMR Shareholding
16th May 20244:11 pmRNSHolding(s) in Company
14th May 202412:05 pmRNSHolding(s) in Company
3rd May 20243:31 pmRNSHolding(s) in Company
2nd May 20249:00 amRNSHolding(s) in Company
22nd Apr 20243:39 pmRNSHolding(s) in Company
18th Apr 20245:33 pmRNSDirector/PDMR Shareholding
17th Apr 20243:07 pmRNSHolding(s) in Company
10th Apr 20243:10 pmRNSHolding(s) in Company
10th Apr 20249:47 amRNSHolding(s) in Company
9th Apr 20249:00 amRNSHolding(s) in Company
8th Apr 20249:00 amRNSHolding(s) in Company
3rd Apr 20245:16 pmRNSHolding(s) in Company
2nd Apr 20249:01 amRNSHolding(s) in Company
2nd Apr 20249:00 amRNSHolding(s) in Company
27th Mar 20241:46 pmRNSHolding(s) in Company
22nd Mar 20243:11 pmRNSHolding(s) in Company
21st Mar 202412:13 pmRNSDirector/PDMR Shareholding
20th Mar 20247:00 amRNSJohnson Matthey sale of Medical Device Components
18th Mar 20243:05 pmRNSHolding(s) in Company
18th Mar 20242:32 pmRNSHolding(s) in Company
12th Mar 20245:12 pmRNSHolding(s) in Company
12th Mar 20249:00 amRNSHolding(s) in Company
11th Mar 20249:00 amRNSHolding(s) in Company
7th Mar 20244:20 pmRNSHolding(s) in Company
22nd Feb 20244:53 pmRNSDirector/PDMR Shareholding
20th Feb 20243:57 pmRNSHolding(s) in Company
19th Feb 20243:12 pmRNSHolding(s) in Company
15th Feb 20249:54 amRNSDirector/PDMR Shareholding
9th Feb 20244:17 pmRNSHolding(s) in Company
9th Feb 202412:31 pmRNSDirector/PDMR Shareholding
8th Feb 20242:17 pmRNSHolding(s) in Company
1st Feb 20244:08 pmRNSHolding(s) in Company
29th Jan 20243:22 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.